Benzinga's Top Downgrades (NTES, GNOM, SFSF, LPNT)

NetEase.com Inc NTES was downgraded by Cowen from "outperform" to "neutral." NTES' shares closed at $53.51 yesterday. NTES' trailing-twelve-month revenue is $843.69 million. UBS downgraded Complete Genomics Inc GNOM from “buy” to “neutral.” GNOM's stock closed at $14.75 yesterday. Complete Genomics' trailing-twelve-month operating margin is -507.54%. JMP Securities downgraded SuccessFactors Inc SFSF from “outperform” to “market perform.” SFSF's shares closed at $38.02 yesterday. SuccessFactors' PEG ratio is 48.74. Analysts at Morgan Stanley downgraded LifePoint Hospitals Inc LPNT from “overweight” to “equal weight.” LPNT's shares closed at $38.68 yesterday. LifePoint Hospitals' trailing-twelve-month profit margin is 4.77%. More Analyst Ratings here